@kurth

Not US, but had some in Mordor :-) Here emerging things also have special government structures supporting and sponsoring them. But it does not mean that all of them become usable in reality product that even only military can use.

@kurth

If you don't know for now. Around 99% of all employees do not get any copyright or even patents for anything they worked on, all is owned by company or government. It is same in all capitalist countries and China also.

@kurth

May be DARPA is different. But in companies patents usually are limited to certain departments and research centers (also in universities it is common practice), they get their name in patents, but frequently they get exact zero payments despite patent being used for very wide consumer tech. I knew few real samples where researchers of former IBM research center (after this it had been Hitachi and after this had been mostly dissolved) did not get any profits from their HDD related patents.

The Regional Expert Committee on Traditional Medicine for COVID-19 formed by the World Health Organization (WHO), the Africa Centre for Disease Control and Prevention and the African Union Commission for Social Affairs has endorsed a protocol for phase III clinical trials of herbal medicine for COVID-19 as well as a charter and terms of reference for the establishment of a data and safety monitoring board for herbal medicine clinical trials.

“Just like other areas of medicine, sound science is the sole basis for safe and effective traditional medicine therapies,” said Dr Prosper Tumusiime, Director of Universal Health Coverage and Life Course Cluster at WHO Regional Office for Africa.

“The onset of COVID-19, like the Ebola outbreak in West Africa, has highlighted the need for strengthened health systems and accelerated research and development programmes, including on traditional medicines,” said Dr Tumusiime.

The endorsed technical documents are aimed at empowering and developing a critical mass of technical capacity of scientists in Africa to conduct proper clinical trials to ensure quality, safety and efficacy of traditional medicines in line with international standards. Phase III clinical trials are pivotal in fully assessing the safety and efficacy of a new medical product. The data safety and monitoring board will ensure that the accumulated studies data are reviewed periodically against participants’ safety. It will also make recommendations on the continuation, modification or termination of a trial based on evaluation of data at predetermined periods during the study.

If a traditional medicine product is found to be safe, efficacious and quality-assured, WHO will recommend for a fast-tracked, large-scale local manufacturing, Dr Tumusiime explained, noting that through the African Vaccine Regulatory Forum, there is now a benchmark upon which clinical trials of medicines and vaccines in the region can be assessed and approved in fewer than 60 days.

https://www.afro.who.int/news/expert-panel-endorses-protocol-covid-19-herbal-medicine-clinical-trials

@kurth

I told the same, but if you work not in lab or university usually it no patent applied at all (as it is unwanted disclosure) and certainly 100% no copyright. At least this is my experience and experience of around 20 people I know who works in US commercial companies. All they get is very strict NDA to sign and sometimes small shares options in case they do something very valuable or if they are very valuable employee be themselves.

Back to airborne stuff

The Centers for Disease Control and Prevention abruptly removed information from its website saying that COVID-19 can spread through the air and that it may travel distances farther than six feet. It also removed statements saying that the virus usually spreads when people inhale particles produced by others.

The CDC and the World Health Organization (WHO) have been reluctant to acknowledge the role that tiny airborne particles might play in disease spread. At the start of the pandemic, the agencies concluded that the coronavirus spread from person to person when they were in close contact with each other, through heavy, large droplets produced when someone who was sick coughed or sneezed.

It is not a surprise as this thing put huge stop sign on social distancing idiocy that all governments so love.

so while the world suffers from a biological attack from a hostile nation, the nation seeks to spy on it's enemies.... https://www.vice.com/en_asia/article/xg89aj/china-has-been-doing-mass-surveillance-on-millions-of-citizens-in-us-uk-australia-and-india

@Vitaliy....except ...they were tracking 10,000 people from...India. No secret there's a disagreement between china and India, which is 'motive'. But your prejudice is too funny.

Coronavirus and office expenses

At least in 3 IT US companies I know all reductions of office expenses due to remote working went to stock buybacks (read - to investors) or to management bonuses. Ordinary workers and lot of small managers got salary cuts, especially ones who had been smart and moved from very expensive areas (top managers openly sent email demanding to inform company about such and that new salary will be from 15% to 30% lower in this case).

I want to find more logic in this photo

It can be good for business to have more tables instead of distance rules, but overall it is pointless.

Children and youth infected with SARS-CoV-2 have milder disease than do adults and, even among those with the recently described multi-system inflammatory syndrome (MIS-C), mortality is rare. The reasons for the differences in clinical manifestations are unknown, but suggest that age-dependent factors may modulate the anti-viral immune response. We compared cytokine, humoral, and cellular immune responses in pediatric (children and youth, age < 24 years) (n=65) and adult (n=60) patients with COVID-19 at a metropolitan hospital system in New York City. The pediatric patients had a shorter length of stay,decreased requirement for mechanical ventilation and lower mortality compared to adults. The serum concentrations of IL-17A and IFN-γ, but not TNF-α or IL-6, were inversely related to age. Adults mounted a more robust T cell response to the viral spike protein compared to pediatric patients as evidenced by increased expression of CD25+ on CD4+ T cells and the frequency of IFN-γ+CD4+T cells. Moreover, serum neutralizing antibody titers and antibody-dependent cellular phagocytosis were higher in adults compared to pediatric COVID-19 patients. The neutralizing antibody titer correlated positively with age and negatively with IL-17A and IFN-γ serum concentrations. There were no differences in anti-spike protein antibody titers to other human coronaviruses. Together these findings demonstrate that the poor outcome in hospitalized adults with COVID-19 compared to children may not be attributable to a failure to generate adaptive immune responses.

https://www.scribd.com/document/477596151/Scitranslmed-abd5487-Full#from_embed

Italy chart

Here we can see main approach used now in most countries - leave people silently suffer and die at home. Such approach also do not require much medicine workers. And allows to not count most deaths as COVID, plus allows to delay deaths as long as you want (as numbers come from much fewer and in tightly controlled sources).